NEW YORK - Johnson & Johnson said Tuesday it has asked the U.S. Food and Drug Administration to authorize a booster shot for its single-dose COVID-19 vaccine as the government looks to expand its booster program.
The company said in a statement that it submitted data to the agency, seeking to receive authorization for Americans 18 and up who previously received the J&J vaccine.While J&J said it submitted data on several different booster intervals, ranging from two to six months, it did not formally recommend one to regulators."Our clinical program has found that a booster of our COVID-19 vaccine increases levels of protection for those who have received our single-shot vaccine to 94 percent," said Dr.